A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia
{{output}}
Chronic lymphocytic leukemia (CLL) is a common, incurable leukemia. Precision treatment for CLL uses genetic testing to align therapeutic selection with patient characteristics. Insurers are uneven in their reimbursement of precision CLL treatment, partly due ... ...
